Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Olainfarm’s Sales in September Are 8.21 Million Euros


Posted on: 17 Oct 16

Olaine, 2016-10-17 15:00 CEST (GLOBE NEWSWIRE) --  

September 2016, consolidated sales Sales, thsnd. EUR Changes to September 2015 Share in total sales
Latvia 2 418 15% 29%
Russia 2 043 -10% 25%
Ukraine 661 -44% 8%
The Netherlands 549 37% 7%
Belarus 544 15% 7%
Kazakhstan 456 281% 6%
UK 302 NA 4%
Spain 129 102% 2%
Denmark 119 NA 1%
Tajikistan 114 188% 1%
Other 879 -36% 11%
Total 8 214 2% 100%

 

Sales of pharmacy chain of SIA Latvijas aptieka in September 2016 were 1.6 million euros, which represents an increase by 12% compared to September 2015. Sixty-two pharmacies were operating during this period.  Sales of SIA Silvanols in September 2016 were .63 million euros, which is an increase by 17% compared to its sales in September of last year. SIA Silvanols sold its products to four European countries and with the help of AS Olainfarm also to Russia, Lithuania and Kazakhstan.  Sales of Tonus Elast in September were 0.53 million euros, and the company sold its products to 16 countries in three continents.

 

According to preliminary consolidated numbers for nine months of 2016, sales of AS Olainfarm have reached 78.51 million euros, which represents an increase by 8% compared to nine months period of 2015.  The biggest sales increase in nine months was achieved in Uzbekistan, where sales grew by 112%.  Sales to Poland grew by 75%, sales to Ukraine grew by 51%.  Major sales markets during this period were Russia, Latvia, Ukraine and Belarus.

 

9 months of 2016, consolidated sales Sales, thsnd. EUR Changes to 9 months of 2015 Share in total sales
Russia 22 989 -7% 29%
Latvia 19 200 15% 24%
Ukraine 12 149 38% 15%
Belarus 6 316 22% 8%
Kazakhstan 2 024 16% 3%
UK 1 891 24% 2%
Uzbekistan 1 780 72% 2%
The Netherlands 1 639 -67% 2%
Turkmenistan 1 067 38% 1%
Lithuania 956 16% 1%
Other 8 496 10% 11%
Total 78 507 8% 100%

 

Sales of pharmacy chain of SIA Latvijas aptieka in nine months were 13.9 million euros, which is an increase by 14% compared to same period of 2015.  Sales of SIA Silvanols in nine months of 2016 were 3.68 million euros, which represents an increase by 27% compared to nine months of last year, when Silvanols’ sales were 2.9 million euros. Products of SIA Silvanols were sold to eleven European countries and with the help of AS Olainfarm, also to Albania, Kosovo, Azerbaijan, Kazakhstan, Belarus and Russia. Sales of SIA Tonus Elast in four months was 2.66 million euros, its products were sold to 30 countries in four continents.

 

According to unconsolidated preliminary results, sales of AS Olainfarm in September 2016 were 6.47 million euro, which represents a reduction by 3% compared to the same period of 2015.  The biggest sales increase was achieved in Kazakhstan, where sales grew by 227%.  Sales to Tajikistan grew by 188%, but sales to Spain grew by 102%.  Significant shipments during this period were also made to the UK and Denmark.  Major sales markets of AS Olainfarm during this period were Russia, Latvia, Ukraine, The Netherlands and Belarus.  During September 2016 AS Olainfarm sold its products in 26 countries in two continents.

September 2016, unconsolidated sales Sales, thsnd. EUR   Changes to September 2015 Share in total sales
Russia 2 043 -10% 32%
Latvia 1 228 7% 19%
Ukraine 628 -47% 10%
The Netherlands 549 37% 8%
Belarus 544 11% 8%
Kazakhstan 391 227% 6%
UK 274 NA 4%
Spain 129 102% 2%
Denmark 119 NA 2%
Tajikistan 114 188% 2%
Other 451 -61% 7%
Total 6 470 -6% 100%

 

According to unconsolidated preliminary results, sales of AS Olainfarm in nine months of 2016 were 66.07 million euros, which represents an increase by 3% compared to nine months of 2015.  The biggest sales increase during this period was achieved in Uzbekistan, where sales grew by 72%.  Sales to Turkmenistan grew by 38%, while sales to Ukraine grew by 37%.  Majors sales markets in nine months of this year were Russia, Ukraine, Latvia and Belarus. In total during this period AS Olainfarm sold its products to 39 countries in four continents.  

 

9 months of 2016, unconsolidated sales Sales, thsnd. EUR Changes to 9 months of 2015 Share in total sales
Russia 22 587 -8% 34%
Ukraine 12 032 37% 18%
Latvia 9 916 8% 15%
Belarus 6 293 22% 10%
UK 1 815 19% 3%
Uzbekistan 1 780 72% 3%
Kazakhstan 1 727 -1% 3%
The Netherlands 1 639 -67% 2%
Turkmenistan 1 067 38% 2%
Lithuania 817 28% 1%
Other 6 401 10% 10%
Total 66 074 3% 100%

 

AGM of AS Olainfarm held on June 7, this year approved operating plan of the Company and the Group, providing that Company’s sales in 2016 will reach 86 million euros, while Group’s sales will reach 100 million euros.  According to these preliminary sales numbers, in nine months of 2016 seventy-seven percent of planned annual Company’s sales and 79% percent of planned annual Group’s sales have been attained.

 

 

 JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

         Information prepared by:
         
         Salvis Lapins
         JSC Olainfarm
         Member of the Management Board
         Rupnicu iela 5, Olaine, Latvia, LV 2114
         Phone: +371 6 7013 717
         Fax: +371 6 7013 777
         E-mail: Salvis.Lapins@olainfarm.lv

GlobeNewswire
globenewswire.com

Last updated on: 18/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.